{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:13:50Z","timestamp":1788092030155,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,30]]},"DOI":"10.7759\/cureus.115429","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:16:25Z","timestamp":1788088585000},"source":"Crossref","is-referenced-by-count":0,"title":["Accuracy of Contrast-Enhanced Mammography (CEM) Compared With Breast MRI in Detecting Residual Disease After Neoadjuvant Therapy: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Yousef","family":"Alalawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan Abdulrahman S","family":"Alamrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashael S","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline","volume":"39","author":"Korde LA","year":"2021","unstructured":"Korde LA, Somerfield MR, Carey LA, et al.. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J Clin Oncol. 2021, 39:1485-505. 10.1200\/JCO.20.03399","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"12","author":"Cortazar P","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, et al.. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014, 12:164-72. 10.1016\/S0140-6736(13)62422-8","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3492","article-title":"Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis","volume":"26","author":"Spring LM","year":"2020","unstructured":"Spring LM, Fell G, Arfe A, et al.. Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis. Clin Cancer Res. 2020, 26:2838-48. 10.1158\/1078-0432.CCR-19-3492","journal-title":"Clin Cancer Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019182947","article-title":"Breast MRI: state of the art","volume":"292","author":"Mann RM","year":"2019","unstructured":"Mann RM, Cho N, Moy L. Breast MRI: state of the art. Radiology. 2019, 292:520-36. 10.1148\/radiol.2019182947","journal-title":"Radiology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.05.023","article-title":"Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy","volume":"48","author":"Houssami N","year":"2012","unstructured":"Houssami N, Macaskill P, von Minckwitz G, Marinovich ML, Mamounas E. Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. Eur J Cancer. 2012, 48:3342-54. 10.1016\/j.ejca.2012.05.023","journal-title":"Eur J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.29365","article-title":"Patients' experience to MRI examinations\u2014a systematic qualitative review with meta-synthesis","volume":"61","author":"Nieto Alvarez I","year":"2025","unstructured":"Nieto Alvarez I, Madl J, Becker L, Amft O. Patients' experience to MRI examinations\u2014a systematic qualitative review with meta-synthesis. J Magn Reson Imaging. 2025, 61:480-93. 10.1002\/jmri.29365","journal-title":"J Magn Reson Imaging"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/1557-3265.SABCS24-P2-09-14","article-title":"Diagnostic accuracy assessing residual disease in breast cancer patients receiving neoadjuvant systemic therapies (NST) is comparable between contrast enhanced mammography(CEM)& breast magnetic resonance imaging(MRI)across various cancer subtypes","volume":"31","author":"Harris W","year":"2025","unstructured":"Harris W, Patel B, Kosiorek H, et al.. Diagnostic accuracy assessing residual disease in breast cancer patients receiving neoadjuvant systemic therapies (NST) is comparable between contrast enhanced mammography(CEM)& breast magnetic resonance imaging(MRI)across various cancer subtypes. Cancer Res. 2025, 31:P2-09-14. 10.1158\/1557-3265.SABCS24-P2-09-14","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2026.111410","article-title":"Comparison of contrast-enhanced mammography and breast MRI in tumour extent assessment: A systematic review and meta-analysis","volume":"52","author":"Ermans SJ","year":"2026","unstructured":"Ermans SJ, Maas R, Hill TM, Usiskin SI, Alic L, Douek M. Comparison of contrast-enhanced mammography and breast MRI in tumour extent assessment: A systematic review and meta-analysis. Eur J Surg Oncol. 2026, 52:111410. 10.1016\/j.ejso.2026.111410","journal-title":"Eur J Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.799209","article-title":"The diagnostic performance of machine learning-based radiomics of DCE-MRI in predicting axillary lymph node metastasis in breast cancer: a meta-analysis","volume":"12","author":"Zhang J","year":"2022","unstructured":"Zhang J, Li L, Zhe X, Tang M, Zhang X, Lei X, Zhang L. The diagnostic performance of machine learning-based radiomics of DCE-MRI in predicting axillary lymph node metastasis in breast cancer: a meta-analysis. Front Oncol. 2022, 12:799209. 10.3389\/fonc.2022.799209","journal-title":"Front Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani M","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016, 5:210. 10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7326\/M22-0276","article-title":"QUAPAS: an adaptation of the QUADAS-2 tool to assess prognostic accuracy studies","volume":"175","author":"Lee J","year":"2022","unstructured":"Lee J, Mulder F, Leeflang M, Wolff R, Whiting P, Bossuyt PM. QUAPAS: an adaptation of the QUADAS-2 tool to assess prognostic accuracy studies. Ann Intern Med. 2022, 175:1010-8. 10.7326\/M22-0276","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-023-06865-8","article-title":"Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment","volume":"198","author":"Hogan MP","year":"2023","unstructured":"Hogan MP, Horvat JV, Ross DS, et al.. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment. Breast Cancer Res Treat. 2023, 198:349-59. 10.1007\/s10549-023-06865-8","journal-title":"Breast Cancer Res Treat"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-025-02068-x","article-title":"Head\u2011to\u2011head comparison of contrast\u2011enhanced mammography and MRI in assessing the tumor response to neoadjuvant therapy in breast cancer: a prospective, multireader study","volume":"130","author":"Wang S","year":"2025","unstructured":"Wang S, Li J, Chen R, et al.. Head\u2011to\u2011head comparison of contrast\u2011enhanced mammography and MRI in assessing the tumor response to neoadjuvant therapy in breast cancer: a prospective, multireader study. Radiol Med. 2025, 130:1561-74. 10.1007\/s11547-025-02068-x","journal-title":"Radiol Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20220921","article-title":"Predicting the response to neoadjuvant chemotherapy. Can the addition of tomosynthesis improve the accuracy of contrast-enhanced spectral mammography? A comparison with breast MRI","volume":"96","author":"Savaridas SL","year":"2023","unstructured":"Savaridas SL, Vinnicombe SJ, Warwick V, Evans A. Predicting the response to neoadjuvant chemotherapy. Can the addition of tomosynthesis improve the accuracy of contrast-enhanced spectral mammography? A comparison with breast MRI. Br J Radiol. 2023, 96:20220921. 10.1259\/bjr.20220921","journal-title":"Br J Radiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics16040640","article-title":"Contrast-enhanced mammography vs. breast MRI for assessing neoadjuvant chemotherapy response: a prospective clinical comparison study","volume":"16","author":"Acar O","year":"2026","unstructured":"Acar O, A\u00e7ar \u00c7R, Orguc \u0130S, Ekinci F, Sahbazlar M, Erdo\u011fan AP. Contrast-enhanced mammography vs. breast MRI for assessing neoadjuvant chemotherapy response: a prospective clinical comparison study. Diagnostics (Basel). 2026, 16:640. 10.3390\/diagnostics16040640","journal-title":"Diagnostics (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.22.27756","article-title":"Contrast-enhanced mammography versus MRI in the evaluation of neoadjuvant therapy response in patients with breast cancer: a prospective study","volume":"219","author":"Bernardi D","year":"2022","unstructured":"Bernardi D, Vatteroni G, Acquaviva A, et al.. Contrast-enhanced mammography versus MRI in the evaluation of neoadjuvant therapy response in patients with breast cancer: a prospective study. AJR Am J Roentgenol. 2022, 219:884-94. 10.2214\/AJR.22.27756","journal-title":"AJR Am J Roentgenol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.senol.2022.04.001","article-title":"Diagnostic accuracy of contrast-enhanced mammography vs MRI in evaluating the response of breast cancer treated with neoadjuvant chemotherapy","volume":"36","author":"L\u00f3pez \u00c1I","year":"2023","unstructured":"L\u00f3pez \u00c1I, Alejandro AB, L\u00f3pez LA, et al.. Diagnostic accuracy of contrast-enhanced mammography vs MRI in evaluating the response of breast cancer treated with neoadjuvant chemotherapy. Rev Senol Patol Mamaria. 2023, 36:100415. 10.1016\/j.senol.2022.04.001","journal-title":"Rev Senol Patol Mamaria"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-023-07034-7","article-title":"Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis","volume":"202","author":"Kaiyin M","year":"2023","unstructured":"Kaiyin M, Lingling T, Leilei T, Wenjia L, Bin J. Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis. Breast Cancer Res Treat. 2023, 202:1-9. 10.1007\/s10549-023-07034-7","journal-title":"Breast Cancer Res Treat"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-09547-7","article-title":"Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis","volume":"33","author":"Ploumen RA","year":"2023","unstructured":"Ploumen RA, de Mooij CM, Gommers S, Keymeulen KB, Smidt ML, van Nijnatten TJ. Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis. Eur Radiol. 2023, 33:5423-35. 10.1007\/s00330-023-09547-7","journal-title":"Eur Radiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2022.1396","article-title":"Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer","volume":"16","author":"Canteros D","year":"2022","unstructured":"Canteros D, Walbaum B, C\u00f3rdova-Delgado M, et al.. Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer. Ecancermedicalscience. 2022, 16:1396. 10.3332\/ecancer.2022.1396","journal-title":"Ecancermedicalscience"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16152694","article-title":"Performance of contrast-enhanced mammography (CEM) for monitoring neoadjuvant chemotherapy response among different breast cancer subtypes","volume":"16","author":"Vidali S","year":"2024","unstructured":"Vidali S, Irmici G, Depretto C, et al.. Performance of contrast-enhanced mammography (CEM) for monitoring neoadjuvant chemotherapy response among different breast cancer subtypes. Cancers (Basel). 2024, 16:2694. 10.3390\/cancers16152694","journal-title":"Cancers (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.111270","article-title":"Is contrast-enhanced mammography (CEM) an alternative to MRI in assessing the response to primary systemic therapy of breast cancer?","volume":"170","author":"Sunen I","year":"2024","unstructured":"Sunen I, Isabel Garcia Barrado A, Cruz Ciria S, Garcia Maroto J, Gros Ba\u00f1eres B, Garcia Mur C. Is contrast-enhanced mammography (CEM) an alternative to MRI in assessing the response to primary systemic therapy of breast cancer?. Eur J Radiol. 2024, 170:111270. 10.1016\/j.ejrad.2023.111270","journal-title":"Eur J Radiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.16.17239","article-title":"Potential cost savings of contrast-enhanced digital mammography","volume":"208","author":"Patel BK","year":"2017","unstructured":"Patel BK, Gray RJ, Pockaj BA. Potential cost savings of contrast-enhanced digital mammography. AJR Am J Roentgenol. 2017, 208:W231-7. 10.2214\/AJR.16.17239","journal-title":"AJR Am J Roentgenol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.21037\/qims.2019.11.09","article-title":"The emerging role of contrast-enhanced mammography","volume":"9","author":"Cozzi A","year":"2019","unstructured":"Cozzi A, Schiaffino S, Sardanelli F. The emerging role of contrast-enhanced mammography. Quant Imaging Med Surg. 2019, 9:2012-8. 10.21037\/qims.2019.11.09","journal-title":"Quant Imaging Med Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/523875-accuracy-of-contrast-enhanced-mammography-cem-compared-with-breast-mri-in-detecting-residual-disease-after-neoadjuvant-therapy-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:16:27Z","timestamp":1788088587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/523875-accuracy-of-contrast-enhanced-mammography-cem-compared-with-breast-mri-in-detecting-residual-disease-after-neoadjuvant-therapy-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.115429","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,30]]}}}